Skip to content

Nasdaq · CIK 0000070487

NRC NRC HEALTH

Insider trading from SEC Form 4. Last filing Jun 25, 2026. Close $20.33 on Oct 9, 2026, +84% from the 52-week low and -10% from the high.

NRC HEALTH (NRC) has 32 SEC Form 4 filings on file from 16 insiders, the latest filed on Jun 25, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

3 open-market trades have been scored at NRC. The newest: Shane R Harrison (EVP & Chief Financial Officer) bought $98k of stock on Feb 17, 2026, filed Feb 19, 2026, scored 48 (moderate).

NRC closed at $20.33 on Oct 9, 2026, 84% above its 52-week low and 10% below its 52-week high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company

Price and insider trades, last year

NRCOct 9, 2026 · close 20.33

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at NRC HEALTH, scored.

ScoreInsiderValueHoldingsPrice contextFiled
48ModerateShane R Harrison
EVP & Chief Financial Officer
buy
$98k
8,000 shares
-+22% from low-46% from high
31WeakJordan Nicole Freeman
Chief Accounting Officer
buy
$10,000
771 shares
-+24% from low-44% from high
16WeakPatrick E Beans
owner
buy
$34k
2,500 shares
+8%-

Transactions

Every row filed, 39 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 23, 2026Parul Bhandari
director
AGrant or award
Common Stock
+7,697$0.00$07,697Jun 25, 2026
Jun 23, 2026Donald M Berwick
director
AGrant or award
Common Stock
+7,697$0.00$07,697Jun 25, 2026
Jun 23, 2026John N Nunnelly
director
AGrant or award
Common Stock
+7,697$0.00$040,363Jun 25, 2026
Jun 23, 2026Stephen H Lockhart
director
AGrant or award
Common Stock
+7,697$0.00$07,697Jun 25, 2026
Jun 23, 2026Penny Ann Wheeler
director
AGrant or award
Common Stock
+7,697$0.00$07,697Jun 25, 2026
Mar 12, 2026Jason Russell Rau
Executive Vice President
AGrant or award
Common Stock
+60,000$0.00$060,000Mar 13, 2026
Feb 17, 2026Shane R Harrison
EVP & Chief Financial Officer
POpen-market purchase
Common Stockindirect: IRA
+8,000$12.27$98k8,000Feb 19, 2026
Jan 22, 2026Parul Bhandari
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+8,819$0.00$08,819Feb 17, 2026
Jan 22, 2026Stephen H Lockhart
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+8,819$0.00$08,819Feb 17, 2026
Dec 29, 2025Shane R Harrison
EVP & Chief Financial Officer
FTax withholding
Common Stock
-21,271$18.66$397k150,729Jan 26, 2026
Jan 5, 2026David Burik
EVP, Strategic Insights
AGrant or award
Common Stock
+100,000$0.00$0100,000Jan 16, 2026
Jan 5, 2026Michael D. Hays
Chairman
MOption exercise
Common Stock
+9,145$15.23$139k20,154Jan 7, 2026
Jan 5, 2026Michael D. Hays
Chairman
MOption exercise
Employee Stock Option (right to buy)derivative
-9,145$0.00$00Jan 7, 2026
Dec 15, 2025Helen Hrdy
EVP & Chief Operating Officer
MOption exercise
Common Stock
+12,346$15.23$188k151,762Dec 17, 2025
Dec 15, 2025Helen Hrdy
EVP & Chief Operating Officer
FTax withholding
Common Stock
-11,244$17.64$198k140,518Dec 17, 2025
Dec 15, 2025Helen Hrdy
EVP & Chief Operating Officer
MOption exercise
Employee Stock Option (right to buy)derivative
-12,346$0.00$00Dec 17, 2025
Oct 17, 2025Donald M Berwick
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+22,625$0.00$022,625Oct 21, 2025
Oct 17, 2025Penny Ann Wheeler
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+22,625$0.00$022,625Oct 21, 2025
Oct 17, 2025John N Nunnelly
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+22,625$0.00$022,625Oct 21, 2025
Sep 29, 2025Shane R Harrison
EVP & Chief Financial Officer
AGrant or award
Common Stock
+172,000$0.00$0172,000Oct 1, 2025
Jul 31, 2025Jordan Nicole Freeman
Chief Accounting Officer
POpen-market purchase
Common Stock
+771$12.97$10,000771Aug 4, 2025
Jun 1, 2025Trent S Green
Chief Executive Officer
AGrant or award
Common Stock
+500,000$0.00$0500,000Jun 3, 2025
May 12, 2025Patrick E Beans
owner
POpen-market purchase
Common Stock
+2,500$13.59$34k35,003May 13, 2025
May 7, 2025Donald M Berwick
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+34,917$0.00$034,917May 9, 2025
May 7, 2025Parul Bhandari
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+34,917$0.00$034,917May 9, 2025
May 7, 2025Stephen H Lockhart
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+34,917$0.00$034,917May 9, 2025
May 7, 2025John N Nunnelly
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+34,917$0.00$034,917May 9, 2025
May 7, 2025Penny Ann Wheeler
director
AGrant or award
Director Stock Option (Right to Buy)derivative
+34,917$0.00$034,917May 9, 2025
Aug 24, 2018Patrick E Beans
owner
GGift
Common Stock
-650$0.00$034,153Apr 10, 2025
Dec 31, 2024Common Property Trust
owner
GGift
Common Stockindirect: By Amandla, LLC
+4,755,317$0.00$04,755,317Apr 10, 2025
Dec 31, 2024Amandla MK Trust
owner
GGift
Common Stockindirect: By Amandla, LLC
-4,755,317$0.00$00Apr 10, 2025
May 10, 2019Patrick E Beans
owner
GGift
Common Stock
-800$0.00$033,353Apr 10, 2025
Jun 25, 2019Patrick E Beans
owner
GGift
Common Stock
-450$0.00$032,903Apr 10, 2025
Dec 3, 2019Patrick E Beans
owner
GGift
Common Stock
-400$0.00$032,503Apr 10, 2025
Apr 7, 2025Andrew Monnich
Chief Corp. Development Off.
AGrant or award
Common Stock
+100,000$0.00$0100,000Apr 9, 2025
Apr 7, 2025Helen Hrdy
Chief Operating Officer
AGrant or award
Common Stock
+100,000$0.00$0139,416Apr 9, 2025
Jan 10, 2025Michael D. Hays
CEO & President
AGrant or award
Employee Stock Option (right to buy)derivative
+11,021$0.00$011,021Jan 14, 2025
Jan 2, 2025Michael D. Hays
CEO & President
MOption exercise
Common Stock
+10,014$13.17$132k11,009Jan 6, 2025
Jan 2, 2025Michael D. Hays
CEO & President
MOption exercise
Employee Stock Option (right to buy)derivative
-10,014$0.00$00Jan 6, 2025

Insiders

Everyone who has filed a Form 4 here.

Questions about NRC

Answered from the filings on this page, as of the latest one.

Are insiders buying NRC?

No. In the last 90 days no insider at NRC HEALTH bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade NRC on the open market?

Shane R Harrison (EVP & Chief Financial Officer) bought $98k of NRC on Feb 17, 2026 and filed the Form 4 on Feb 19, 2026. InsiderTell scored 48 (moderate).

How many insiders file Form 4 at NRC HEALTH?

16 people have filed a Form 4 at NRC HEALTH, among them Amandla MK Trust (10% owner), Patrick E Beans (10% owner), Donald M Berwick (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

NRC insider trading: NRC HEALTH | InsiderTell